RxDoctor Payments Data

Jaelyn Yount, APRN

Family · Sneedville, TNNPI 1477171817

Payments from drug & device makers

$383in general payments, 2019–2025

Across 16 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$102
  • Bayer$84
  • AbbVie$70
  • Exact Sciences$39
  • Vanda Pharmaceuticals Inc.$22
  • Novo Nordisk$20
  • plus $47 from 3 others

What the payments were for

  • Food & beverage$383100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$383 in reported general payments places this provider in the 45th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,588
Medicare patients
50
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin99$99,389
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$35,605
JanuviaSitagliptin Phosphate20$31,511
Tresiba Flextouch U-100Insulin Degludec28$31,387
TrulicityDulaglutide14$23,570
EliquisApixaban30$23,072
OzempicSemaglutide20$22,007
TradjentaLinagliptin31$21,281
LinzessLinaclotide24$15,489
Keppra XrLevetiracetam13$14,716
Lantus SolostarInsulin Glargine,hum.Rec.Anlog74$11,251
FarxigaDapagliflozin Propanediol11$9,469
Spiriva HandihalerTiotropium Bromide17$8,610
Breo ElliptaFluticasone/Vilanterol21$8,378
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$5,390

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$16$120,670130 claims
GSKTrelegy Ellipta, Breo Ellipta$102$43,98373 claims
Novo NordiskOzempic, Novolog$20$24,70932 claims
Lilly USA, LLCTrulicity$16$23,57014 claims
AbbVieLinzess$70$15,48924 claims
AstraZenecaFarxiga, Symbicort$15$14,02028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 6,706 family providers in Tennessee.

Other family in Sneedville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →